×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Image search
Paste the image URL
Home
Faculties & Institutes
Scholars
Publications
Statistics
News
Search in the results
Faculties & Institutes
Institute of Chi... [2]
Authors
XIN CHEN [5]
HU YUANJIA [2]
HU HAO [1]
Document Type
Book chapter [2]
Journal article [2]
Other [1]
Date Issued
2022 [1]
2019 [3]
2018 [1]
Language
英語English [4]
Source Publication
Progress in Mole... [2]
Biomedicine and ... [1]
Cancer Immunothe... [1]
FRONTIERS IN IMM... [1]
Indexed By
SCIE [3]
BKCI-S [1]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-5 of 5
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Submit date Ascending
Submit date Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
Issue Date Ascending
Issue Date Descending
Author Ascending
Author Descending
Title Ascending
Title Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Scutellarin enhances anti-tumor immune responses by reducing TNFR2-expressing CD4+Foxp3+ regulatory T cells
Journal article
Biomedicine and Pharmacotherapy, 2022,Volume: 151
Authors:
Chen, Shaokui
;
Li, Ruixin
;
Chen, Yibo
;
Chou, Chon Kit
;
Zhang, Zhexuan
;
Yang, Yang
;
Liao, Ping
;
Wang, Qingqing
;
Chen, Xin
Favorite
|
|
TC[WOS]:
0
TC[Scopus]:
0
|
Submit date:2022/08/02
Cancer Immunotherapy
cd4+foxp3+ Regulatory t Cells
Cpg Oligodeoxynucleotide
Scutellarin
Tumor Necrosis Factor
Tumor Necrosis Factor Receptor Ii
TNFR2-expressing CD4(+) Foxp3(+) regulatory T cells in cancer immunology and immunotherapy
Book chapter
出自: Cancer Immunotherapy:Elsevier, 2019, 页码: 101-117
Authors:
Jiang He
;
Ruixin Li
;
Yibo Chen
;
Yuanjia Hu
;
Xin Chen
Favorite
|
|
TC[WOS]:
12
TC[Scopus]:
10
|
Submit date:2019/05/08
TNFR2 and Regulatory T Cells: Potential Immune Checkpoint Target in Cancer Immunotherapy
Book chapter
出自: Progress in Molecular Biology and Translational Science:ELSEVIER ACADEMIC PRESS INC, 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA, 2019, 页码: 101-117
Authors:
Jiang He
;
Ruixin Li
;
Yibo Chen
;
Yuanjia Hu
;
Xin Chen
Favorite
|
|
TC[WOS]:
12
TC[Scopus]:
10
|
Submit date:2020/05/05
Regulatory t Cells
Tumor Necrosis Factor Receptor Type 2
Cancer
Immunotherapy
Tumor Necrosis Factor
TNFR2-expressing CD4+ Foxp3+ regulatory T cells in cancer immunology and immunotherapy
Other
2019-01-01
Authors:
He, J.
;
Li, Ruixin
;
Chen, Yibo
;
Hu, Yuanjia
;
Chen, Xin
Favorite
|
|
TC[WOS]:
12
TC[Scopus]:
10
|
Submit date:2022/05/23
Cancer
Immunotherapy
Regulatory T cells
Tumor necrosis factor
Tumor necrosis factor receptor type 2
Modulation of Regulatory T Cell Activity by TNF Receptor Type II-Targeting Pharmacological Agents
Journal article
FRONTIERS IN IMMUNOLOGY, 2018,Volume: 9
Authors:
Zou, Huimin
;
Li, Ruixin
;
Hu, Hao
;
Hu, Yuanjia
;
Chen, Xin
Favorite
|
|
TC[WOS]:
32
TC[Scopus]:
30
|
Submit date:2018/10/30
Tnf Receptor Type Ii
Regulatory t Cells
Tnf Receptor Type Ii Agonists
Tnf Receptor Type Ii Antagonists
Immunotherapy